Samir Kakodkar, MD, a specialist in Crohn's disease and ulcerative colitis, provides a review of ozanimod, which is a once-daily, oral medication for moderate to severe ulcerative colitis. Dr Kakodkar discusses efficacy and safety results from the True North study. He provides his opinions regarding ozanimod and other medications according to his review of the literature and his personal/clinical experience.